Getting Zepbound covered by insurance requires meeting specific clinical criteria, navigating a prior authorization process, and being prepared to appeal if your first request is denied. Most insurers do cover Zepbound under certain conditions, but the approval process involves more documentation than a typical prescription. Here’s what you need to know at each step.
Who Qualifies Based on FDA Labeling
Insurance companies use the FDA-approved label as their starting point for coverage decisions. Zepbound is approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher when accompanied by at least one weight-related health condition such as high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease. Your insurer will verify that you meet one of these thresholds before considering approval.
Many insurers set the bar even higher than the FDA label. Some require a BMI of 35 or above, or require that you have multiple related conditions rather than just one. Before your doctor submits anything, it’s worth calling your insurance company or checking your plan’s formulary online to see what your specific plan requires.
What Prior Authorization Involves
Nearly every Zepbound prescription requires prior authorization, a coverage request your doctor submits to your insurance company with clinical details about your weight, health history, and previous weight management efforts. This is the single most important step in the process, and being well-prepared for it significantly improves your chances.
When your doctor fills out the prior authorization form, they’ll need to document your current weight and BMI, any weight-related conditions you have, how long you’ve been managing your weight, and what you’ve already tried. Come to your appointment ready to discuss your full history. If you’ve worked with a dietitian, tried structured meal plans, or used other weight loss medications, bring that information. The more thoroughly your doctor can document your case, the stronger your request will be.
Your doctor may also submit a letter of medical necessity alongside the prior authorization form. This letter explains in clinical terms why Zepbound is the appropriate treatment for your specific situation, connecting your diagnosis codes, health risks, and treatment history into a clear argument for coverage.
Step Therapy Requirements
Many insurers won’t approve Zepbound as a first-line treatment. They require “step therapy,” meaning you must try and fail on lower-cost options before they’ll cover a newer, more expensive medication. The specifics vary by plan, but a common pattern looks like this:
- Weight loss program enrollment: Some plans require documentation that you’ve been actively participating in a physician-directed weight loss program for at least six months, including a reduced-calorie diet, increased physical activity, and behavioral modification. You may also need to show you’ll continue the program while taking Zepbound.
- Prior medication trials: If you have type 2 diabetes, some insurers require that you’ve tried and failed at least three consecutive months on other medications in the same drug class before approving Zepbound. Exceptions exist if you experienced significant side effects or if those medications are contraindicated for you.
If you suspect your plan has step therapy requirements, ask your insurer directly what they need. Knowing this upfront can save you months of back-and-forth. Your doctor can document any past medication trials or lifestyle interventions retroactively if you’ve already gone through them.
Medicare and Medicaid Coverage
Medicare has historically not covered anti-obesity medications, but that’s changing. CMS is launching the Medicare GLP-1 Bridge, a short-term demonstration program running from July 1, 2026, through December 31, 2027, that will cover Zepbound for eligible Medicare Part D beneficiaries. The program has stricter criteria than the FDA label: you’ll need a BMI of 35 or higher, or a BMI of 30 or higher with a qualifying condition like heart failure with preserved ejection fraction, uncontrolled high blood pressure despite two medications, or chronic kidney disease stage 3a or above. Beneficiaries with a BMI of 27 or higher can also qualify with a history of pre-diabetes, heart attack, stroke, or symptomatic peripheral artery disease.
Only the KwikPen formulation of Zepbound will be covered through this bridge program, not the single-dose pen or single-dose vial. You must be enrolled in a standalone prescription drug plan or a Medicare Advantage plan with drug coverage to participate.
Medicaid coverage varies significantly by state. California’s Medi-Cal program, for example, stopped covering Zepbound for weight loss indications as of January 1, 2026, though it may still cover it for obstructive sleep apnea or other non-weight-loss indications with an approved prior authorization. Check with your state Medicaid program directly, as policies differ widely.
What to Do if You’re Denied
A denial is not the end of the road. Appeals succeed more often than most people expect, particularly when the denial was based on incomplete information. Start by finding out exactly why you were denied. The three most common categories are: the procedure is excluded from your plan, the insurer considers it not medically necessary, or they’ve classified it as experimental.
For each type, the response is slightly different but follows the same core strategy. First, verify that your doctor used the correct diagnostic codes on the claim. An incorrect code can trigger an automatic denial that has nothing to do with your actual eligibility. Second, make sure every relevant health condition is documented. If you have sleep apnea, high blood pressure, diabetes, or heart disease in addition to obesity, each condition strengthens your case. Third, ask your doctor to write a detailed letter connecting your diagnoses, your treatment history, and the clinical rationale for why Zepbound is necessary for you specifically.
If your plan says the treatment is excluded entirely, review your plan documents carefully. Some employer-sponsored plans have blanket exclusions for weight management medications, in which case an appeal may not help. But if the exclusion seems to be a coding issue or a misclassification, resubmitting with corrected documentation and a strong medical necessity letter can overturn the decision. You typically have at least one level of internal appeal, and if that fails, most states allow you to request an external review by an independent third party.
Manufacturer Savings if Insurance Falls Short
Eli Lilly offers a savings card for people who have commercial (employer or marketplace) insurance that doesn’t cover Zepbound. To qualify, you need a valid prescription consistent with the FDA-approved label and commercial drug insurance that specifically does not cover the medication. The card allows up to 13 prescription fills per calendar year for the single-dose pen, or up to 11 fills per year for the KwikPen. It expires December 31, 2026, and terms can change at Lilly’s discretion.
People on government insurance, including Medicare, Medicaid, TRICARE, and VA benefits, are not eligible for the savings card. If you’re in that group and your coverage denies the medication, your options are more limited: appealing the denial, asking your doctor about alternative covered medications, or waiting for programs like the Medicare GLP-1 Bridge to begin.
Steps to Take Right Now
Call your insurance company and ask three specific questions: Is Zepbound on your formulary? What prior authorization criteria does your plan require? And does your plan have step therapy or lifestyle program requirements? Write down the answers, including the name of the representative you spoke with and the date.
Then schedule an appointment with your doctor to discuss your full weight management history. Bring records of any previous weight loss programs, medications you’ve tried, and a list of all weight-related conditions you’ve been diagnosed with. The goal is to give your doctor everything they need to submit the strongest possible prior authorization on your first attempt. A well-documented initial request is your best chance at avoiding a denial and the weeks-long appeal process that follows.